We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MGNI:NASDAQMagnite, Inc. Analysis

Data as of 2026-04-17 - not real-time

$13.64

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Magnite (MGNI) is trading at $13.64, just above its 20‑day ($12.19) and 50‑day ($12.34) moving averages but well below the 200‑day level ($17.63), signaling a short‑term bounce within a longer‑term downtrend. The 14‑day RSI sits at 66, indicating the stock is approaching overbought territory. A bullish MACD histogram (+0.21) and a line above the signal line reinforce the possibility of near‑term upside. Volume has been trending down, suggesting limited buying pressure ahead of the $13.75 resistance zone. The computed beta of 1.56 and a 30‑day volatility of 42% point to a highly volatile, market‑sensitive instrument. Yet the DCF‑derived fair value of $13.95 is only marginally above the current price, implying limited immediate upside from intrinsic valuation alone. Analyst consensus is strongly positive, with a “strong_buy” rating and median price target of $21.50, translating to an implied upside of roughly 58%.
On the fundamentals side, MGNI delivered $714 M in revenue with 5.9% YoY growth and robust profitability—gross margin of 62.7% and operating margin of 25.4%. Net profit margin of 20.3% and ROE of 17% underscore efficient capital utilization. The balance sheet shows $553 M cash offset by $626 M debt, yielding a debt‑to‑equity of 68%, a leverage level that warrants monitoring. A trailing P/E of 14.4 is well below the industry average of 19.2, positioning the stock as relatively undervalued on a value basis. No dividend is paid, so income‑focused investors should look elsewhere. The company’s focus on programmatic CTV and AI‑driven ad automation aligns with secular digital‑advertising trends, offering a growth catalyst beyond the current earnings pace. In sum, while short‑term price action may be constrained by technical resistance, the combination of solid margins, attractive valuation multiples, and a bullish analyst outlook supports a buy stance for medium‑ to long‑term horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but price near resistance at $13.75
  • RSI approaching overbought levels
  • Decreasing volume indicating limited short‑term buying pressure

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued P/E relative to industry peers
  • Strong profit margins and cash generation
  • Analyst median target of $21.50 implying substantial upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular growth in programmatic and CTV advertising
  • AI‑driven platform positioning as a competitive advantage
  • Solid balance sheet with ample cash despite moderate leverage

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin20.26%
P/E Ratio14.4
ROE17.11%
ROA2.03%
Debt/Equity67.91
P/B Ratio2.1
Op. Cash Flow$236.2M
Free Cash Flow$119.6M
Industry P/E19.2

Technical Analysis

TrendBearish
RSI66.0
Support$11.36
Resistance$13.75
MA 20$12.18
MA 50$12.34
MA 200$17.63
MACDBullish
VolumeDecreasing
Fear & Greed Index89.39

Valuation

Fair Value$13.95
Target Price$22.07
Upside/Downside61.81%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.56
Volatility42.00%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.